Cingulate Inc. SEC filings CINGW
Cingulate Inc. has 493 filings in SEC EDGAR's recent list, going back to May 24, 2021. Its latest annual report, Form ARS, was filed on May 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 15, 2026 | — |
| 424B3 | Prospectus | Apr 28, 2026 | — |
| S-3 | Shelf registration | Apr 14, 2026 | — |
| 424B3 | Prospectus | Mar 27, 2026 | — |
| 424B3 | Prospectus | Mar 24, 2026 | — |
| S-3/A | Filing | Mar 23, 2026 | — |
| S-3 | Shelf registration | Mar 20, 2026 | — |
| S-3 | Shelf registration | Jan 12, 2026 | — |
| 424B5 | Prospectus supplement | Jan 12, 2026 | — |
| 424B3 | Prospectus | Jul 30, 2025 | — |
| S-8 | Employee stock plan registration | Jul 25, 2025 | — |
| S-1/A | Amended registration statement | Jul 25, 2025 | — |
| S-1 | Registration statement | Jul 22, 2025 | — |
| 424B5 | Prospectus supplement | Oct 15, 2024 | — |
| 424B3 | Prospectus | Oct 7, 2024 | — |
| S-1/A | Amended registration statement | Oct 7, 2024 | — |
| S-1/A | Amended registration statement | Oct 3, 2024 | — |
| S-1 | Registration statement | Sep 27, 2024 | — |
| 424B5 | Prospectus supplement | Sep 3, 2024 | — |
| 424B3 | Prospectus | Aug 27, 2024 | — |
| S-1 | Registration statement | Aug 19, 2024 | — |
| 424B5 | Prospectus supplement | Aug 19, 2024 | — |
| 424B3 | Prospectus | Jul 24, 2024 | — |
| S-8 | Employee stock plan registration | Jul 15, 2024 | — |
| S-3 | Shelf registration | Jul 15, 2024 | — |
| 424B3 | Prospectus | May 23, 2024 | — |
| S-1 | Registration statement | May 17, 2024 | — |
| S-8 | Employee stock plan registration | Apr 4, 2024 | — |
| 424B4 | Prospectus | Apr 3, 2024 | — |
| POS AM | Filing | Apr 1, 2024 | — |
| 424B5 | Prospectus supplement | Mar 18, 2024 | — |
| 424B4 | Prospectus | Feb 5, 2024 | — |
| S-1/A | Amended registration statement | Jan 29, 2024 | — |
| S-1 | Registration statement | Jan 12, 2024 | — |
| S-1 | Registration statement | Nov 15, 2023 | — |
| 424B4 | Prospectus | Sep 12, 2023 | — |
| S-1/A | Amended registration statement | Sep 7, 2023 | — |
| S-1/A | Amended registration statement | Aug 29, 2023 | — |
| S-1/A | Amended registration statement | Aug 22, 2023 | — |
| S-1 | Registration statement | Jul 25, 2023 | — |
| 424B4 | Prospectus | May 19, 2023 | — |
| POS AM | Filing | May 12, 2023 | — |
| 424B5 | Prospectus supplement | May 5, 2023 | — |
| 424B4 | Prospectus | May 2, 2023 | — |
| S-1 | Registration statement | Apr 26, 2023 | — |
| S-8 | Employee stock plan registration | Mar 13, 2023 | — |
| S-1 | Registration statement | Mar 10, 2023 | — |
| 424B3 | Prospectus | Jan 13, 2023 | — |
| S-3 | Shelf registration | Jan 3, 2023 | — |
| 424B3 | Prospectus | Nov 14, 2022 | — |
| 424B3 | Prospectus | Aug 11, 2022 | — |
| 424B3 | Prospectus | May 13, 2022 | — |
| 424B4 | Prospectus | Apr 20, 2022 | — |
| POS AM | Filing | Apr 14, 2022 | — |
| S-8 | Employee stock plan registration | Mar 30, 2022 | — |
| 424B4 | Prospectus | Dec 9, 2021 | — |
| S-1/A | Amended registration statement | Nov 30, 2021 | — |
| S-1/A | Amended registration statement | Nov 10, 2021 | — |
| S-1/A | Amended registration statement | Oct 12, 2021 | — |
| S-1/A | Amended registration statement | Oct 1, 2021 | — |
| S-1/A | Amended registration statement | Sep 27, 2021 | — |
| S-1 | Registration statement | Sep 9, 2021 | — |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CING (Nasdaq), CINGW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Kansas City, KS
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1862150
- Former names
- Cingulate Inc. (until Oct 2, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.